Lars Anders

3.2k total citations · 2 hit papers
12 papers, 1.5k citations indexed

About

Lars Anders is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lars Anders has authored 12 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lars Anders's work include Advanced Breast Cancer Therapies (5 papers), Cancer-related Molecular Pathways (4 papers) and Protein Degradation and Inhibitors (3 papers). Lars Anders is often cited by papers focused on Advanced Breast Cancer Therapies (5 papers), Cancer-related Molecular Pathways (4 papers) and Protein Degradation and Inhibitors (3 papers). Lars Anders collaborates with scholars based in United States, Belgium and Germany. Lars Anders's co-authors include Yoojin Choi, Richard A. Young, Piotr Siciński, Per Hydbring, Yoon Jong Choi, Nan Rosemary Ke, Stephen P. Gygi, Huili Zhai, Pascal Falter‐Braun and Marc Vidal and has published in prestigious journals such as Science, Nature Biotechnology and Molecular and Cellular Biology.

In The Last Decade

Lars Anders

12 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element

2014 538 citations Marc R. Mansour, Brian J. Abraham et al. Science profile →
A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer Cells

2011 431 citations Lars Anders, Nan Rosemary Ke et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lars Anders United States	7	1.1k	497	306	223	131	12	1.5k
Susan Korenchuk United States	13	896 0.9×	348 0.7×	462 1.5×	204 0.9×	76 0.6×	18	1.4k
Rajani Kanteti United States	21	761 0.7×	513 1.0×	446 1.5×	219 1.0×	135 1.0×	40	1.4k
Nathan V. Lee United States	14	673 0.6×	459 0.9×	326 1.1×	312 1.4×	150 1.1×	23	1.2k
Katti Jessen United States	12	1.3k 1.2×	389 0.8×	157 0.5×	184 0.8×	90 0.7×	27	1.6k
Motoyoshi Tanaka Japan	22	919 0.9×	361 0.7×	244 0.8×	258 1.2×	208 1.6×	49	1.5k
William Senapedis United States	29	1.6k 1.5×	661 1.3×	193 0.6×	202 0.9×	128 1.0×	79	2.1k
Nino Keshelava United States	19	914 0.9×	454 0.9×	120 0.4×	293 1.3×	96 0.7×	33	1.4k
Chun-Ju Chang United States	9	980 0.9×	529 1.1×	146 0.5×	445 2.0×	79 0.6×	10	1.3k
Yoon Jong Choi United States	11	1.3k 1.2×	813 1.6×	449 1.5×	240 1.1×	286 2.2×	19	1.9k
Yoko Ueno Japan	13	901 0.9×	377 0.8×	217 0.7×	123 0.6×	69 0.5×	19	1.4k

Countries citing papers authored by Lars Anders

Since Specialization

Citations

This map shows the geographic impact of Lars Anders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Anders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Anders more than expected).

Fields of papers citing papers by Lars Anders

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Anders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Anders. The network helps show where Lars Anders may publish in the future.

Co-authorship network of co-authors of Lars Anders

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Anders. A scholar is included among the top collaborators of Lars Anders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Anders. Lars Anders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Anders, Lars, Todd Van Arsdale, Sudhakar Chintharlapalli, et al.. (2024). 354P Synergistic preclinical efficacy through combination of the CDK4 and CDK2 selective inhibitors, PF-07220060 and PF-07104091, respectively, in HR+ HER2- breast cancer. Annals of Oncology. 35. S365–S365. 1 indexed citations

Shen, Chen, Ming Qiu, Nanni Huser, et al.. (2024). Abstract 5709: PF-07104091, a first-in-class CDK2-selective inhibitor for the treatment of HR+/HER2- breast cancer and CCNE1high ovarian cancer. Cancer Research. 84(6_Supplement). 5709–5709. 6 indexed citations

Anders, Lars & Gary M. Gallego. (2024). Abstract ND12: Discovery of PF-07220060, a potent and selective CDK4 inhibitor. Cancer Research. 84(7_Supplement). ND12–ND12. 2 indexed citations

Sanda, Takaomi, Brian J. Abraham, Adam D. Durbin, et al.. (2016). Abstract 2007: Transcriptional regulatory program controlled by the oncogenic transcription factor LMO1 in neuroblastoma. Cancer Research. 76(14_Supplement). 2007–2007. 1 indexed citations

Mansour, Marc R., Brian J. Abraham, Lars Anders, et al.. (2014). An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science. 346(6215). 1373–1377. 538 indexed citations breakdown →

Anders, Lars, Matthew G. Guenther, Jun Qi, et al.. (2014). Genome-wide determination of drug localization. Digital Access to Scholarship at Harvard (DASH) (Harvard University). 137 indexed citations

Choi, Yoon Jong, Borja Sáez, Lars Anders, et al.. (2014). D-Cyclins Repress Apoptosis in Hematopoietic Cells by Controlling Death Receptor Fas and Its Ligand FasL. Developmental Cell. 30(3). 255–267. 23 indexed citations

Bhalla, Kavita, Keyata N. Thompson, Lars Anders, et al.. (2014). Cyclin D1 Represses Gluconeogenesis via Inhibition of the Transcriptional Coactivator PGC1α. Diabetes. 63(10). 3266–3278. 45 indexed citations

Anders, Lars, Matthew G. Guenther, Jun Qi, et al.. (2013). Genome-wide localization of small molecules. Nature Biotechnology. 32(1). 92–96. 1 indexed citations

10.

Choi, Yoojin & Lars Anders. (2013). Signaling through cyclin D-dependent kinases. Oncogene. 33(15). 1890–1903. 225 indexed citations

11.

Anders, Lars, Nan Rosemary Ke, Per Hydbring, et al.. (2011). A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer Cells. Cancer Cell. 20(5). 620–634. 431 indexed citations breakdown →

12.

Anders, Lars, Philipp Mertins, Sven Lammich, et al.. (2006). Furin-, ADAM 10-, and γ-Secretase-Mediated Cleavage of a Receptor Tyrosine Phosphatase and Regulation of β-Catenin's Transcriptional Activity. Molecular and Cellular Biology. 26(10). 3917–3934. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact